Inventor · disambiguated record
Eric P. Gillis
Also filed as: GILLIS ERIC · GILLIS ERIC P
37 granted patents·19 pending applications·192 citations·filing 2007–2024
97Inventor score
Files withBRISTOL MYERS SQUIBB CO18VIIV HEALTHCARE UK NO 5 LTD17UNIV ILLINOIS11BURKE MARTIN D7HIEBERT SHELDON1
Top patents by PatentIndex Score
56 records- 0197US9732119B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 15, 2017·14 cites·8 claims
- 0296US9308236B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 12, 2016·51 cites·5 claims
- 0395US9879046B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 30, 2018·17 cites·12 claims
- 0495US8338601B2Slow release of organoboronic acids in cross-coupling reactionsBURKE MARTIN D·Filed 2009·Granted Dec 25, 2012·14 cites·22 claims
- 0594US8013203B2System for controlling the reactivity of boronic acidsUNIV ILLINOIS·Filed 2007·Granted Sep 6, 2011·13 cites·24 claims
- 0693US10143746B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 4, 2018·9 cites·17 claims
- 0792US9850283B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 26, 2017·12 cites·1 claims
- 0891US12129255B2Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2020·Granted Oct 29, 2024·2 cites·21 claims
- 0990US11541055B2Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Jan 3, 2023·3 cites·28 claims
- 1090US8318983B2System for controlling the reactivity of boronic acidsBURKE MARTIN D·Filed 2011·Granted Nov 27, 2012·6 cites·22 claims
- 1189US9328102B2Slow release of organoboronic acids in cross-coupling reactionsUNIV ILLINOIS·Filed 2015·Granted May 3, 2016·2 cites·12 claims
- 1289US9006463B2Slow release of organoboronic acids in cross-coupling reactionsUNIV ILLINOIS·Filed 2012·Granted Apr 14, 2015·3 cites·19 claims
- 1388US9944678B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 17, 2018·8 cites·2 claims
- 1487US10450347B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 22, 2019·6 cites·23 claims
- 1587US10358463B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 23, 2019·7 cites·15 claims
- 1686US11505543B24-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Nov 22, 2022·3 cites·4 claims
- 1784US10538555B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 21, 2020·8 cites·3 claims
- 1883US10239824B2Automated synthesis of small molecules using chiral, non-racemic boronatesUNIV ILLINOIS·Filed 2016·Granted Mar 26, 2019·1 cites·16 claims
- 1981US9238597B2Apparatus and methods for the automated synthesis of small moleculesBURKE MARTIN D·Filed 2011·Granted Jan 19, 2016·3 cites·20 claims
- 2081US8557980B2Methods for forming protected organoboronic acidsBURKE MARTIN D·Filed 2011·Granted Oct 15, 2013·3 cites·18 claims
- 2178US9012658B2Automated synthesis of small molecules using chiral, non-racemic boronatesBURKE MARTIN D·Filed 2012·Granted Apr 21, 2015·1 cites·17 claims
- 2277US9845317B2Slow release of organoboronic acids in cross-coupling reactionsUNIV ILLINOIS·Filed 2016·Granted Dec 19, 2017·1 cites·16 claims
- 2376US2025019383A1Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2024·Application pending·0 cites
- 2476US2024374598A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2024·Application pending·0 cites
- 2575US10752577B2Automated synthesis of small molecules using chiral, non-racemic boronatesUNIV ILLINOIS·Filed 2019·Granted Aug 25, 2020·0 cites·7 claims
- 2675US8957203B2Hepatitis C virus inhibitorsHIEBERT SHELDON·Filed 2012·Granted Feb 17, 2015·4 cites·3 claims
- 2774US2021009508A1Automated Synthesis of Small Molecules Using Chiral, Non-Racemic BoronatesUNIV ILLINOIS·Filed 2020·Application pending·0 cites
- 2870US2023109662A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LLIMITED·Filed 2022·Application pending·0 cites
- 2966US9527885B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 27, 2016·1 cites·8 claims
- 3063US9388131B2Automated synthesis of small molecules using chiral, non-racemic boronatesUNIV ILLINOIS·Filed 2015·Granted Jul 12, 2016·0 cites·20 claims
- 3163US9328127B2System for controlling the reactivity of boronic acidsUNIV ILLINOIS·Filed 2012·Granted May 3, 2016·0 cites·23 claims
- 3262US9732102B2System for controlling the reactivity of boronic acidsUNIV ILLINOIS·Filed 2016·Granted Aug 15, 2017·0 cites·19 claims
- 3361US2021379071A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
- 3460US9908900B2Methods for forming protected organoboronic acidsUNIV ILLINOIS·Filed 2016·Granted Mar 6, 2018·0 cites·17 claims
- 3560US9353131B2Methods for forming protected organoboronic acidsBURKE MARTIN D·Filed 2013·Granted May 31, 2016·0 cites·11 claims
- 3657US2017369530A1Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 3755US9868743B2Macrocyclic molecules as HCV entry inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 16, 2018·0 cites·2 claims
- 3855US9862733B2Apparatus and methods for the automated synthesis of small moleculesBURKE MARTIN D·Filed 2016·Granted Jan 9, 2018·0 cites·20 claims
- 3955US2023355626A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 4054US2021393633A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
- 4153US2023106880A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 4252US2022370451A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2020·Application pending·0 cites
- 4352US2023013823A1Inhibitors of human immunodeficiency virus replicationVIV HEALTHCARE UK NO 5 LTD·Filed 2020·Application pending·0 cites
- 4451US9643999B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 9, 2017·0 cites·16 claims
- 4551US2022389007A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2020·Application pending·0 cites
- 4649US9422311B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 23, 2016·0 cites·15 claims
- 4748US2023149408A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 4847US2021403465A1Quinazolinyl-indazole derivatives and their use as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
- 4947US2021395262A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
- 5046US2021395248A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eric P. Gillis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →